Palantir Is Down 11% Over 12 Months: This Wall Street Pro Says 50% Gains to Come Over Next 12 Months as Momentum Rises

Palantir shares are down 11.04% over 12 months and 10.31% over the past week, but Barclays’ $265 target implies 48.6% upside from $178.34; the 31-analyst consensus target of $212.50 implies 19.2%. Third-quarter revenue rose 95.9% to $2.31 billion, adjusted EPS of $0.44 beat the $0.41 estimate, and management raised full-year revenue guidance to $8.530 billion–$8.534 billion. The bullish case is tempered by a forward P/E of 86, stock-based compensation of $318.9 million, and receivables rising to $1.88 billion; the article’s author remains cautiously bullish if commercial growth continues and contract value catches up with revenue.

Analysis

The key underwriting issue is conversion, not headline growth. If AIP onboarding is creating durable demand, contract value should eventually validate revenue and receivables should convert to cash. Until then, rapid reported growth alongside weak contract-value growth, rising receivables and higher stock compensation leaves room for a quality-of-earnings repricing. Verify receivables aging/collections, dilution, and the next contract-value disclosure; analyst targets and adjusted EPS beats do not resolve those questions.

Near term (days to weeks): PLTR remains exposed to high-multiple software de-risking. The 200-day average near $153.57 is a useful technical risk marker, not fundamental support. A break would increase the chance that systematic and momentum selling overwhelms earnings optimism. Next 1–3 months: the next results and cash-conversion evidence matter more than target revisions. 6–18 months: sustained commercial adoption could support operating leverage, but any deceleration would have an outsized valuation effect at the cited forward multiple.

The contrarian opportunity is that the selloff may be pricing in a slowdown before commercial demand has demonstrably rolled over. Conversely, the article’s bullish consensus and street-high target are not independent evidence of value. SNOW’s larger target-implied upside is not itself a reason to own it; compare actual growth durability and valuation before rotating. The relative setup favors waiting for PLTR’s contract-value and collection data rather than buying solely on the drawdown.

Key Decisions for Investors

• Keep PLTR on a catalyst watch; consider a staged long only if the next disclosure shows contract value improving and receivables converting to cash. Use a close below the cited $153.57 200-day average as a technical thesis warning, not an automatic fundamental stop.
• For downside control, avoid adding into weakness before those data arrive. Reassess after the next earnings release: persistent contract-value lag, worsening collections, or rising dilution would falsify the bullish conversion thesis and argue for reducing exposure.
• Do not treat the $265 analyst target or SNOW’s higher implied upside as trade signals. Any PLTR-versus-SNOW rotation should wait for comparable valuation, growth, and cash-conversion evidence; those data are not provided here.